FAILDEX失樂園
中文

Juul (partial)

The business, the turning points, and the decisions behind them.

Founded2015
Event year2022
FundingUS$14B
ValuationUS$38B

01 / WHAT IT BUILT

What the company did

Juul Labs was a San Francisco-based e-cigarette company founded in 2015 as a spin-off of PAX Labs by Adam Bowen and James Monsees. Its sleek USB-drive-shaped vaporizer with pre-filled nicotine pods became the dominant e-cigarette in the United States, riding explosive growth to a $38 billion valuation after tobacco giant Altria paid $12.8 billion for a 35% stake in December 2018.

02 / Juul (partial) FAILURE REASONS

Failure reasons

Juul collapsed under regulatory and legal pressure after its products became the center of the U.S. teen vaping epidemic. FDA scrutiny of its marketing and sales practices, a marketing denial order in June 2022, flavor restrictions, state and federal lawsuits, and multibillion-dollar legal settlements destroyed its growth story and its valuation. Altria wrote its $12.8 billion investment down by more than 95%, eventually exiting the stake in 2023, while Juul went through repeated rounds of layoffs and a shrinking revenue base.

03 / EVENT HISTORY

Events in the structured record

  1. Founded

    Juul Labs was founded in San Francisco as a spin-off of PAX Labs by Adam Bowen and James Monsees, selling a compact vaporizer with pre-filled nicotine pods.

  2. Altria takes a 35% stake

    In December 2018 Altria paid $12.8 billion for a 35% stake in Juul, valuing the company at $38 billion at the peak of the vaping boom.

  3. Regulatory backlash and layoffs

    Under fire over teen vaping, CEO Kevin Burns stepped down in September 2019 and was replaced by Altria executive K.C. Crosthwaite; the company announced 400-600 job cuts, and Altria wrote its investment down by $4.5 billion to a $24 billion valuation.

  4. First settlements

    Juul began settling marketing lawsuits, including a $40 million settlement with North Carolina in July 2021 over teen marketing.

  5. FDA denial order and mass settlements

    On June 23, 2022 the FDA issued a marketing denial order directing Juul to pull its products from U.S. shelves; in September 2022 Juul agreed to pay nearly $440 million to settle a two-year investigation by 33 states, while Altria cut its stake valuation to $450 million.

  6. Altria exits

    In March 2023 Altria exchanged its Juul stake for a license to some of Juul's intellectual property, ending its ownership; the FTC dropped its antitrust complaint in July 2023.

04 / CONTEMPORARY REBUILD ASSESSMENT

Difficulty of rebuilding this project today

Material for this section is being gathered and checked. It will appear here once ready.

Rebuild difficultyPending assessmentNot completed
Scoring basisNot completed
ScalabilityPending assessmentNot completed
Scoring basisNot completed

Overall assessment: Not completed

05 / CAUSAL CHAIN

How the factors connect

  1. 01

    Altria's $12.8 billion investment for a 35% stake (December 2018, $38 billion valuation) was written down by $4.5 billion in October 2019 and further to $450 million by July 2022, a loss of more than 95% of its value.

  2. 02

    Juul agreed to pay nearly $440 million in September 2022 to settle a two-year investigation by 33 states over its marketing practices.

  3. 03

    Total legal settlements over teen vaping and marketing claims reached nearly $3 billion, draining the company's finances.

  4. 04

    The company went through multiple rounds of layoffs and a sharp revenue decline from its 2018 peak.

  5. 05

    In March 2023 Altria exited its stake entirely, exchanging it for IP licensing rights, leaving Juul independent but diminished.